Clinical Trial Update: A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR [Phase 1]

View source ↗

Summary

Phase I trial evaluating the safety and immunogenicity of heterologous boost immunizations with the HIV vaccine MVA-CMDR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MVA-CMDR

Snippet

Sponsor: Rockefeller University | Conditions: HIV | Phase 1 | Status: COMPLETED